Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Organigram Holdings Inc. buy Subdi

Start price
€5.44
13.03.20 / 50%
Target price
€9.32
24.07.20
Performance (%)
-15.48%
End price
€4.60
24.07.20
Summary
This prediction ended on 24.07.20 with a price of €4.60. The prediction for Organigram Holdings Inc. disappointed with a performance of -15.48%. Subdi has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Organigram Holdings Inc. -12.069% -12.069% -12.431% -82.759%
iShares Core DAX® 1.883% 5.122% 21.667% 22.437%
iShares Nasdaq 100 0.125% 2.574% 45.951% 55.507%
iShares Nikkei 225® -0.201% 4.341% 28.806% 9.945%
iShares S&P 500 0.728% 4.141% 34.630% 50.086%

Comments by Subdi for this prediction

In the thread Organigram Holdings Inc. diskutieren
Prediction Buy
Perf. (%) -15.48%
Target price 1.800
Change
Ends at 24.07.20

Neustart


Die letze Buy Empfehlung habe ich bei 1,58 beendet.

Im letzten Mai war die Aktie noch bis übe 7€ wert. Wir sind jetzt in der Nähe des Tiefs von 2017. In diesem Bereich sollte der Absturz ein Ende finden. 

Organigram hat eine solide Finanzierung, niedrige Produktionskosten, einen funktionierenden Vertrieb mit treuen Stammkunden, einen guten Ruf in der Szene, und steht nahe der Gewinnschwelle. Kein Vergleich mit Aurora. 

Erstes Kursziel 1,80 - dann sehen wir weiter.

Prediction Buy
Perf. (%) -15.48%
Target price 2.330
Change
Ends at 24.07.20

Kursziel geändert auf 2,33

MONCTON, Canada (AP) _ OrganiGram Holdings Inc. (OGI) on Tuesday reported a loss of $64.8 million in its fiscal third quarter.
The Moncton, Canada-based company said it had a loss of 37 cents per share. Earnings, adjusted for non-recurring costs and asset impairment costs, came to less than 1 cent on a per-share basis.
The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 2 cents per share.
The cannabis producer posted revenue of $13 million in the period, which did not meet Street forecasts. Six analysts surveyed by Zacks expected $16.4 million.

The company's shares closed at $1.52. A year ago, they were trading at $6.43.
https://www.bigrapidsnews.com/business/article/OrganiGram-Fiscal-3Q-Earnings-Snapshot-15422632.php

In the thread Trading Organigram Holdings Inc.
Prediction Buy
Perf. (%) -15.48%
Target price 2.330
Change
Ends at 24.07.20

Buy beendet

Stopped prediction by Subdi for Organigram Holdings Inc.

buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.19
08.08.20
€23.20
04.11.21
200.33%
26.03.21

buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€6.68
14.09.17
€32.00
09.03.20
-5.39%
09.03.20

buy
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€6.64
14.03.17
€11.21
30.06.17
-11.07%
30.06.17